MedPath
NMPA Approval

雷公藤内酯

国药准字H35021304

August 16, 2024

Drug Information

雷公藤内酯

原料药

化学药品

August 16, 2024

Company Information

Applicant Company

福建省三明市三元区台江路46号

Manufacturing Company

福建省三明市三元区台江路46号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

雷公藤内酯 - NMPA 批准文号 | MedPath